Background: Montreal Cognitive Assessment (MoCA) has been shown to be a sensitive tool for cognitive assessment. There are high proportion of Malaysian elderly with limited proficiency in English language. Malay language is a more familiar language across the multiracial population of Malaysia. Objective: The aim of this study is to validate the Malay version of Montreal Cognitive Assessment (MMoCA) in cognitive impairment patients. Methods: Elderly aged 60 years and above were recruited by using convenient sampling method from 4 government hospitals. Subjects were categorized into normal control group versus patients group with cognitive impairment (Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI)). All subjects completed MMoCA & MMSE – Malay version, followed by a second assessment, which involved Clinical Dementia Rating (CDR), clinical neurological and psychiatry assessment. Results: Total of 66 subjects was enrolled in the study, 44 were normal control, 14 with AD, 8 with MCI. MMoCA is better than MMSE-Malay in differentiating CDR 0 from CDR > 0. With the cut off point of less than 22, MMoCA has the sensitivity of 0.824 and specificity of 0.818 to detect cognitive impairment. Whereas MMSE-Malay only has sensitivity of 0.765 and specificity of 0.636 with the cut off point of less than 27. Conclusion: The MMoCA is a validated and useful cognitive screening instrument in patients with cognitive impairment.
| Published in | Clinical Medicine Research (Volume 3, Issue 3) |
| DOI | 10.11648/j.cmr.20140303.11 |
| Page(s) | 56-60 |
| Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
| Copyright |
Copyright © The Author(s), 2014. Published by Science Publishing Group |
MMSE – Malay: Malay version of Mini Mental State Examination, MMoCA: Malay version of Montreal Cognitive Assessment, CDR: Clinical Dementia Rating,AD: Alzheimer’s Disease, MCI: Mild Cognitive Impairment
| [1] | Asia Pacific Members of Alzheimer’s Disease International, Dementia in the Asia Pacific region: The epidermic is here, executive summary of a report by Access economy pty limited, 2006. |
| [2] | Department of Statistics Malaysia, Population distribution and basic demographic characteristic report 2010. |
| [3] | Ziad S. Nasreddine, Natalie A. Phillips, Valerie Bedirian, Simon Charbonneau, Victor Whitehead, Isabelle Collin et al, The Montreal cognitive assessment, MOCA: A brief screening tool for mild cognitive impairment, Journal of America Geriatric Society, 2005;53(4): 695-99 |
| [4] | McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM, Clinical diagnosis of Alzheimer’s disease: Report of the NINCDS-ADRDA workgroup under the auspices of department of health and human services task force on Alzheimer’s disease, Journal of Neurology, 1984; 34(7): 939-44. |
| [5] | Morris JC, The Clinical Dementia Rating (CDR) : Current version and scoring rules, Journal of Neurology, 1993; 43(11): 2412-14 |
| [6] | Folstein MF, Folstein SE, McHugh PR, Mini Mental State: A practical method for grading the cognitive state of patients for the clinician, Journal of Psychiatric Research, 1975; 12(3): 189-98 |
| [7] | Zarina ZA, Zahiruddin O, Che Wan AH, Validation of Malay mini mental state examination, Malaysia Journal of Psychiatry, 2007; 16(1): 16-19. |
APA Style
Wee Kooi Cheah, Hoon Lang Teh, Diana Xiao Han Huang, Alan Swee Hock Ch’ng, Mun Pung Choy, et al. (2014). Validation of Malay Version of Montreal Cognitive Assessment in Patients with Cognitive Impairment. Clinical Medicine Research, 3(3), 56-60. https://doi.org/10.11648/j.cmr.20140303.11
ACS Style
Wee Kooi Cheah; Hoon Lang Teh; Diana Xiao Han Huang; Alan Swee Hock Ch’ng; Mun Pung Choy, et al. Validation of Malay Version of Montreal Cognitive Assessment in Patients with Cognitive Impairment. Clin. Med. Res. 2014, 3(3), 56-60. doi: 10.11648/j.cmr.20140303.11
AMA Style
Wee Kooi Cheah, Hoon Lang Teh, Diana Xiao Han Huang, Alan Swee Hock Ch’ng, Mun Pung Choy, et al. Validation of Malay Version of Montreal Cognitive Assessment in Patients with Cognitive Impairment. Clin Med Res. 2014;3(3):56-60. doi: 10.11648/j.cmr.20140303.11
Share This Article
Twitter
Linked In
Facebook
Copy
Download@article{10.11648/j.cmr.20140303.11,
author = {Wee Kooi Cheah and Hoon Lang Teh and Diana Xiao Han Huang and Alan Swee Hock Ch’ng and Mun Pung Choy and Ewe Eow Teh and Irene Looi},
title = {Validation of Malay Version of Montreal Cognitive Assessment in Patients with Cognitive Impairment},
journal = {Clinical Medicine Research},
volume = {3},
number = {3},
pages = {56-60},
doi = {10.11648/j.cmr.20140303.11},
url = {https://doi.org/10.11648/j.cmr.20140303.11},
eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.cmr.20140303.11},
abstract = {Background: Montreal Cognitive Assessment (MoCA) has been shown to be a sensitive tool for cognitive assessment. There are high proportion of Malaysian elderly with limited proficiency in English language. Malay language is a more familiar language across the multiracial population of Malaysia. Objective: The aim of this study is to validate the Malay version of Montreal Cognitive Assessment (MMoCA) in cognitive impairment patients. Methods: Elderly aged 60 years and above were recruited by using convenient sampling method from 4 government hospitals. Subjects were categorized into normal control group versus patients group with cognitive impairment (Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI)). All subjects completed MMoCA & MMSE – Malay version, followed by a second assessment, which involved Clinical Dementia Rating (CDR), clinical neurological and psychiatry assessment. Results: Total of 66 subjects was enrolled in the study, 44 were normal control, 14 with AD, 8 with MCI. MMoCA is better than MMSE-Malay in differentiating CDR 0 from CDR > 0. With the cut off point of less than 22, MMoCA has the sensitivity of 0.824 and specificity of 0.818 to detect cognitive impairment. Whereas MMSE-Malay only has sensitivity of 0.765 and specificity of 0.636 with the cut off point of less than 27. Conclusion: The MMoCA is a validated and useful cognitive screening instrument in patients with cognitive impairment.},
year = {2014}
}
TY - JOUR T1 - Validation of Malay Version of Montreal Cognitive Assessment in Patients with Cognitive Impairment AU - Wee Kooi Cheah AU - Hoon Lang Teh AU - Diana Xiao Han Huang AU - Alan Swee Hock Ch’ng AU - Mun Pung Choy AU - Ewe Eow Teh AU - Irene Looi Y1 - 2014/04/30 PY - 2014 N1 - https://doi.org/10.11648/j.cmr.20140303.11 DO - 10.11648/j.cmr.20140303.11 T2 - Clinical Medicine Research JF - Clinical Medicine Research JO - Clinical Medicine Research SP - 56 EP - 60 PB - Science Publishing Group SN - 2326-9057 UR - https://doi.org/10.11648/j.cmr.20140303.11 AB - Background: Montreal Cognitive Assessment (MoCA) has been shown to be a sensitive tool for cognitive assessment. There are high proportion of Malaysian elderly with limited proficiency in English language. Malay language is a more familiar language across the multiracial population of Malaysia. Objective: The aim of this study is to validate the Malay version of Montreal Cognitive Assessment (MMoCA) in cognitive impairment patients. Methods: Elderly aged 60 years and above were recruited by using convenient sampling method from 4 government hospitals. Subjects were categorized into normal control group versus patients group with cognitive impairment (Alzheimer’s Disease (AD) and Mild Cognitive Impairment (MCI)). All subjects completed MMoCA & MMSE – Malay version, followed by a second assessment, which involved Clinical Dementia Rating (CDR), clinical neurological and psychiatry assessment. Results: Total of 66 subjects was enrolled in the study, 44 were normal control, 14 with AD, 8 with MCI. MMoCA is better than MMSE-Malay in differentiating CDR 0 from CDR > 0. With the cut off point of less than 22, MMoCA has the sensitivity of 0.824 and specificity of 0.818 to detect cognitive impairment. Whereas MMSE-Malay only has sensitivity of 0.765 and specificity of 0.636 with the cut off point of less than 27. Conclusion: The MMoCA is a validated and useful cognitive screening instrument in patients with cognitive impairment. VL - 3 IS - 3 ER -
Email: